comparemela.com

Latest Breaking News On - Twve - Page 1 : comparemela.com

a16z Perennial Management L P Invests $392,000 in Wave Life Sciences Ltd (NASDAQ:WVE)

a16z Perennial Management L.P. acquired a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 77,619 shares of the company’s stock, valued at approximately $392,000. Wave Life Sciences comprises 0.1% […]

Wave Life Sciences (NASDAQ:WVE) Shares Up 5 5%

Wave Life Sciences Ltd. (NASDAQ:WVE – Get Free Report)’s share price shot up 5.5% during trading on Wednesday . The company traded as high as $5.30 and last traded at $5.20. 174,697 shares were traded during trading, a decline of 79% from the average session volume of 818,906 shares. The stock had previously closed at […]

Wave Life Sciences (WVE) Scheduled to Post Quarterly Earnings on Wednesday

Wave Life Sciences (NASDAQ:WVE – Get Free Report) is scheduled to be announcing its earnings results before the market opens on Wednesday, March 6th. Analysts expect the company to announce earnings of ($0.21) per share for the quarter. Wave Life Sciences Price Performance Shares of WVE traded down $0.09 during midday trading on Thursday, reaching […]

Newtyn Management LLC Purchases 10,000 Shares of Wave Life Sciences Ltd (NASDAQ:WVE)

Newtyn Management LLC increased its stake in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 2.0% during the 3rd quarter, Holdings Channel reports. The firm owned 510,000 shares of the company’s stock after purchasing an additional 10,000 shares during the quarter. Wave Life Sciences comprises approximately 0.7% of Newtyn Management LLC’s portfolio, making the […]

Wave Life Sciences Ltd (NASDAQ:WVE) Receives $8 40 Consensus Price Target from Analysts

Wave Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) has received an average recommendation of “Moderate Buy” from the six research firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12-month target […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.